Vitiligo is signified by acquired white or hypopigmented macules or patches. Affected areas are generally well differentiated, and are spherical, oblong, or linear in shape. Borders can be convex . Generally, the lesions grow centrifugally as the time passes at an erratic rate. Size of the lesions can differ from millimeters to centimeters. In the beginning, lesions appear very often on the hands, forearms, feet, and face. Perioral and periocular areas are most favorable sites.
Vitiligo lesions may be seen only in an area or many areas all over the body, but commonly it widely affects the entire body. In such cases, the macules are generally seen on both sides of the trunk, either evenly or unevenly aligned.
Vitiligo commonly affects the face, neck, and scalp. Mostly, it affects the areas that are subjected to recurrent trauma. Common involvements are bony prominences, extensor surface of forearm, ventral aspects of wrists, dorsal side of hands, and digital phalanges.
Mucous membranes are involved in cases of generalized vitiligo. It generally develops surrounding the body orifices like the lips, genitals, gingiva, areolas, and nipples.
Depigmented body hair (leukotrichia) can be seen in vitiliginous macules. Vitiligo affecting the scalp develops as a limited area of white or gray hair, but complete depigmentation of entire scalp hair may take place. Scalp is involved very frequently, followed by the eyebrows, axillary hair, and pubic hair.
Entire Body System
Jaw & Teeth
We report the case of a 17-year-old boy who presented to our clinic with trauma-induced skin blistering, alopecia, deafness, dental caries, nail dystrophy and vitiliginous areas. [ncbi.nlm.nih.gov]
The other autoimmune disorders associated with vitiligo in our study were alopecia areata, diabetes mellitus, and Rheumatoid arthritis. [omicsonline.org]
Alopecia areata and vitiligo share genetic risk factors and can co-occur within families and individual patients, suggesting a common pathogenesis. 9 As such, it is not surprising that a medication that has been shown to be effective in treating alopecia [jamanetwork.com]
In vitiligo and piebaldism the lack of melanin in the epidermis is due to the fact that melanocytes are missing. [ncbi.nlm.nih.gov]
Schwartz, Piebaldism: an update, International Journal of Dermatology, 43, 10, (716-719), (2004). [doi.org]
ISBN 1-4160-2999-0. v t e Pigmentation disorders/Dyschromia (L80–L81, 709.0) Hypo-/ leucism Loss of melanocytes Vitiligo Quadrichrome vitiligo Vitiligo ponctué Syndromic Alezzandrini syndrome Vogt–Koyanagi–Harada syndrome Melanocyte development Piebaldism [en.wikipedia.org]
Albinism, piebaldism, and other genetic disorders – Begin in infancy. Lichen sclerosus – Look for sclerotic plaques, often in the genital area; can be severely pruritic. [visualdx.com]
- Koebner Phenomenon
According to Falabella,  a lesion with lack of progression or no new lesions for 2 years, absence of recent Koebner phenomenon, positive minigrafting test, absence of Koebner phenomenon at donor site, and evidence of repigmentation of existing patches [jcasonline.com]
Evaluation was also made by dermatologists to define vitiligo subtype, body surface area, Koebner phenomenon (KP), and so on. Data were assessed by computer software. Results were considered statistically significant if p < 0.05. [ncbi.nlm.nih.gov]
Types & treatments Childhood eczema Adult eczema Insider secrets Types of hair loss Treatment for hair loss Causes of hair loss Hair care matters Insider secrets What is psoriasis Diagnosis & treatment Skin, hair & nail care Triggers Insider secrets What [aad.org]
Post-inflammatory hypopigmentation, following inflammatory skin conditions such as eczema. Pityriasis alba. This may be a type of eczema or an inflammatory reaction following mild eczema. Leprosy, especially the tuberculoid variety. Halo naevus. [patient.info]
In the control group of 50 cases of chronic eczema, 3(6%) cases had the evidence of presence of autoimmune disorders, 2(4%) cases had alopecia areata and 1(2%) case had hyperthyroidism. [omicsonline.org]
- Premature Graying of the Hair
In addition to white patches, vitiligo can cause premature graying of the hair. Credit: Wikimedia Commons Vitiligo is believed to affect 0.5 percent to 1 percent of the world's population, or up to 65 million people. [cbsnews.com]
This process happens with hair all over the body, including pubic hair. In some cases, hair may prematurely age and gray. Again, premature graying can affect hair anywhere, including on the pubic region. [medicalnewstoday.com]
In some families, premature graying of the hair results from an autoimmune loss of melanocytes in the hair follicles. [nytimes.com]
graying hair and hair loss may also occur. [winchesterhospital.org]
Sometimes kids with vitiligo have other symptoms, such as premature graying of the hair or a loss of pigment on the lips, since pigment cells are found in these places, too. Causes Theories vary on what causes vitiligo. [kidshealth.org]
Hermanski-Pudlak syndrome Menkès syndrome Ziprkowski-Margolis syndrome Griscelli’s syndrome Post-inflammatory hypomelanoses Related to an increased epidermal turn over Psoriasis Atopic dermatitis Related to an acute lichenoid/cytotoxic infiltrate with pigment incontinence [ncbi.nlm.nih.gov]
- Genital Lesions
Acrofacial: it can affect, face, head, hands and feet, and preferably involve the perioral region and the extremities of digits; Mucosal: affects the oral and genital mucosae. [dx.doi.org]
Diagnosis of vitiligo usually is made with the help of clinical findings, but sometimes biopsy is beneficial in individualization of vitiligo from various hypopigmentary disorders.
Vitiligo is sometimes seen along with various autoimmune diseases like thyroid disease, diabetes mellitus, pernicious anemia, Addison disease, and alopecia areata. Individuals should have knowledge about manifestations of these diseases. In case the disease is manifested than necessary tests should be done . Vitiligo lesions are analyzed with the help of a Wood lamp.
No drug can stop the process of vitiligo, but some drugs when used individually, or along with light therapy, may be helpful in improving the skin's appearance.
- Local application: A topical corticosteroid may help repigment the skin, especially when used in the beginning of the disease. For several months there might be no change in skin color. Topical calcipotriene which is a form of vitamin D may be used along with corticosteroids or ultraviolet light. Ointments comprising of tacrolimus or pimecrolimus (calcineurin inhibitors) can be beneficial for people with tiny areas of depigmentation, particularly on the face and neck.
- Combined medication and light therapy: In this treatment a drug called psoralen is combined with light therapy (photochemotherapy) to regain color on the light patches. Once psoralen is taken by mouth or applied on the affected skin, than the person is exposed to ultraviolet A (UVA) or UVB light. The drug affects your skin in such a way that the skin becomes more sensitive to the light, and it turns pink. As the skin starts healing, normal skin color starts appearing.
- Light therapy: In this therapy narrow band UVB light is used. Maximum results are seen on the face, trunk and limbs
- Laser therapy: In this treatment an excimer laser is used to bring back the color in areas of light skin. It makes use of a particular wavelength of UVB light. This laser can be used on small areas only, and is generally used along with a drug applied on the skin.
- Removing the remaining color (depigmentation): This therapy is considered if the vitiligo is widespread and other treatments have failed. A medication containing monobenzone is applied on normal areas of skin. Because of this, the normal skin gradually lightens and blends with discolored skin.
- Surgery is the last option for those in whom light therapy and drugs do not have any effect. Various procedures like skin grafting, blister grafting or tattooing are used to cover the patches.
Generally, limited vitiligo involving the face and trunk in children of recent onset is very receptive to treatment. Wide-spread disease in adults and disease affecting the hands and feet is resistant to therapy.
The incidence worldwide is less than 1% . Around 30% of the cases are seen within a group of members in a family. Appearance of the vitiligo is independent of the age, although the onset is usually observed in persons aged 10-30 years. In most of the cases, the person suffers from vitiligo at early age in life.
Vitiligo can be caused by both genetic and non-genetic factors. Even though the actual cause remains unknown, commonly considered factors are that there are no functional melanocytes left in the affected skin and there is damage of histochemically identified melanocytes, leading to their destruction. Theories regarding destruction of melanocytes include the following:
Autoimmune destruction of melanocytes
The autoimmune theory  suggests changes in humoral and cellular immunity in the devastation of melanocytes of vitiligo. The most assuring data of an autoimmune involvement is the existence of circulating antibodies in persons suffering from vitiligo . Substantial data points towards link between cellular immunity and vitiligo.
Intrinsic defect of melanocytes
Vitiligo melanocytes might have an intrinsic defect causing death of melanocyte. These melanocytes exhibit different abnormalities like unusual, harsh endoplasmic reticulum and inadequate synthesis and transformation of melanocytes.
Disruption in oxidant-antioxidant mechanism in vitiligo
Studies suggest that piling up of free radicals lethal to melanocytes results in their devastation. Current investigations are deployed to figure out the action of oxidative stress by calculating the levels of antioxidant enzymes superoxide dismutase (SOD) and catalase (CAT) in the affected as well as the unaffected skin of patients suffering from vitiligo and in the skin of totally unaffected control persons. It was proved that oxidative stress is raised in vitiligo, as determined by increased levels of SOD and decreased levels of CAT in the skin of people suffering from vitiligo .
Case reports portray that patients suffering from an injury to nerve along with having vitiligo, are also suffering from hypopigmentation or depigmentation in those denervated regions. In addition, segmental vitiligo regularly develops in a dermatomal pattern, which indicates that some chemical mediators are liberated from nerve endings affecting the melanin production. Additionally, sweating and vasoconstriction are raised in depigmented patches of vitiligo, suggesting high adrenergic activity. Ultimately, increased excretion of homovanillic acid and vanillylmandelic acid in urine has been recorded in patients suffering from vitiligo. This can be a basic or trivial episode .
Genetics of vitiligo
Vitiligo is characterized by partial penetrance, many sensitive areas, and genetic heterogeneity . Vitiligo caused due to inheritance can be due to involvement of genes related to the biosynthesis of melanin, reaction to oxidative stress, and control of autoimmunity .
There is no way to prevent vitiligo, but using sunscreens with a minimum sun protection factor (SPF) of 15 to protect the skin from the sun is always a healthy decision.
Vitiligo is a condition that causes depigmentation of segments of the skin. Being a genetic disorder there is no way of preventing this disease; it is advised to start the treatment as early as possible. As the disease is associated with various other autoimmune diseases, care must be taken to diagnose and treat them too. Emotional support is another important part of vitiligo therapy as the skin changes caused by vitiligo can affect people emotionally and socially.
Even in today’s world due to unawareness people feel that vitiligo can also spread due to close contact but that is not true, vitiligo is not a communicable disease. It does not cause any disability and the patient is fit for any type of work. Now due to progress in cosmetic industry there are many local applications that are available to hide small areas of vitiligo on the exposed area. The creams camouflages with the skin such that no one can make out the difference.
- Halder RM, Chappell JL. Vitiligo update. Semin Cutan Med Surg. 2009 Jun;28(2):86-92.
- Nath SK, Majumder PP, Nordlund JJ. Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet. 1994 Nov;55(5):981-90.
- Le Poole IC, Luiten RM. Autoimmune etiology of generalized vitiligo. Curr Dir Autoimmun. 2008;10:227-43.
- Toussaint S, Kamino H. Noninfectous papular and squamous diseases. In: Elder D, Elenitas R, Jaworsky D, Johnson B Jr. Lever's Histopathology of the Skin. Philadelphia, Pa: Lippincot-Raven; 1997:154-5.
- Sravani PV, Babu NK, Gopal KV, Rao GR, Rao AR, Moorthy B. Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin. Indian J Dermatol Venereol Leprol. 2009 May-Jun;75(3):268-71.
- Kovacs SO. Vitiligo. J Am Acad Dermatol. 1998 May;38(5 Pt 1):647-66; quiz 667-8.
- Spritz RA. The genetics of generalized vitiligo. Curr Dir Autoimmun. 2008;10:244-57.
- Halder R, Taliaferro S. Vitiligo. In: Wolff K, Goldsmith L, Katz S, Gilchrest B, Paller A, Lefell D, eds.Fitzpatrick's Dermatology in General Medicine. Vol 1. 7th ed. New York, NY: McGraw-Hill; 2008:72.
- Ortonne J. Vitiligo and other disorders of Hypopigmentation. In: Bolognia J, Jorizzo J, Rapini R, eds.Dermatology. Vol 1. 2nd. Spain: Elsevier; 2008:65.
- Matz H, Tur E. Vitiligo. Curr Probl Dermatol. 2007;35:78-102.